Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 10
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP22F2117 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-01-18 | 2022-01-25 | 325412 | 8508811868!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2114 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $440.47K | 2022-01-18 | 2022-01-25 | 325412 | 8508811862!ADENOVIRUS TYPE 4 A |
| SPE2DP22F1330 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-12-07 | 2021-12-14 | 325412 | 8508730950!ADENOVIRUS TYPE 4 A |
| SPE2DP22F1327 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-12-07 | 2021-12-14 | 325412 | 8508730895!ADENOVIRUS TYPE 4 A |
| SPE2DP22F1324 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-12-07 | 2021-12-14 | 325412 | 8508730817!ADENOVIRUS TYPE 4 A |
| SPE2DP22F1323 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-12-07 | 2021-12-14 | 325412 | 8508730814!ADENOVIRUS TYPE 4 A |
| SPE2DP22F0708 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-11-09 | 2021-11-16 | 325412 | 8508670193!ADENOVIRUS TYPE 4 A |
| SPE2DP22F0707 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-11-09 | 2021-11-16 | 325412 | 8508670190!ADENOVIRUS TYPE 4 A |
| SPE2DP22F0706 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-11-09 | 2021-11-16 | 325412 | 8508670110!ADENOVIRUS TYPE 4 A |
| SPE2DP21F5500 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-08-11 | 2021-08-24 | 325412 | 8508433264!ADENOVIRUS TYPE 4 A |
| SPE2DP21F5487 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-08-11 | 2021-08-24 | 325412 | 8508432584!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4961 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-07-13 | 2021-07-20 | 325412 | 8508354221!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4299 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-06-08 | 2021-06-22 | 325412 | 8508275913!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3781 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-05-06 | 2021-05-25 | 325412 | 8508191840!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3774 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-05-06 | 2021-05-25 | 325412 | 8508191710!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3772 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-05-06 | 2021-05-25 | 325412 | 8508191574!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3210 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-04-06 | 2021-04-27 | 325412 | 8508113866!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3209 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-04-06 | 2021-04-27 | 325412 | 8508113865!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2628 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-03-10 | 2021-03-23 | 325412 | 8508045107!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2627 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-03-10 | 2021-03-23 | 325412 | 8508045102!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2622 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-03-10 | 2021-03-23 | 325412 | 8508044768!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2054 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-02-11 | 2021-02-23 | 325412 | 8507981309!ADENOVIRUS TYPE 4 A |
| SPE2DP21F2053 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-02-11 | 2021-02-23 | 325412 | 8507981302!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1536 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $423.53K | 2021-01-14 | 2021-01-26 | 325412 | 8507913388!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1005 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $407.24K | 2020-12-07 | 2020-12-15 | 325412 | 8507846276!ADENOVIRUS TYPE 4 A |